Evidence map›Paper›PMID 35011501›Full record

ArticleMolecules (Basel, Switzerland)2022

Anti-Inflammatory and Antiproliferative Properties of Sweet Cherry Phenolic-Rich Extracts.

Ana C Gonçalves, Ana R Costa, José D Flores-Félix, Amílcar Falcão, Gilberto Alves, Luís R Silva

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Bioactive Potential of Sweet Cherry (Foods (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Biochemical andFood chemistry. Molecular sciences · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana C GonçalvesCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.ORCID 0000-0001-7795-795X
Ana R CostaCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.ORCID 0000-0002-9673-4337
José D Flores-FélixCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.ORCID 0000-0003-2200-4400
Amílcar FalcãoCIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3004-531 Coimbra, Portugal.ORCID 0000-0002-3854-6549
Gilberto AlvesCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.ORCID 0000-0002-4213-0714
Luís R SilvaCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.ORCID 0000-0001-5264-3516

Funding

Fundação para a Ciência e Tecnologia 2020.04947.BDFundação para a Ciência e Tecnologia UI/BD/151025/2021
6 · The paper itself

Abstract

Cherries have largely been investigated due to their high content in phenolics in order to fully explore their health-promoting properties. Therefore, this work aimed to assess, for the first time, the anti-inflammatory potential of phenolic-targeted fractions of the

Indexed as

AdenocarcinomaAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicNeuroblastomaStomach NeoplasmsAnimalsCell Line, TumorCell ProliferationFruitHumansMicePlant ExtractsPrunus aviumRAW 264.7 CellsAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicPlant Extractsanti-inflammatorycytotoxicityoxidative stressphenolic compoundssweet cherries

Identifiers

PMID35011501
PMCPMC8747005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.